SmallCap
CompaniesStatistics

(주)셀엔백스

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)셀엔백스
Business Reg. No.1458702582
CEO신현진
Address대전광역시 유성구
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products백신, 진단키트, 치료제 외
EstablishedContact
Phone042-821-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.160111-*******

Investment Metrics


Market Cap
-
Op. Margin
-
ROE
265.87%
Debt Ratio
-503.18%

Certification Status


Venture Certified

Cert. History
연구개발유형2023-04-27 ~ 2026-04-26202304270200032023-04-27

Financial Statements


3-Year Financial Data
Item202420232022
Revenue

0.0B

0.0B

0.0B

Operating Profit

-7.7B

-2.6B

-1.9B

Net Profit

-6.1B

-2.6B

-1.9B

Total Assets

9.3B

4.8B

6.1B

Total Liabilities

11.6B

1.6B

0.3B

Total Equity

-2.3B

3.2B

5.8B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
0

- 0.0%

vs. 3-Year Avg.: 0
Operating Profit
-8B

244.3%

vs. 3-Year Avg.: -2B
Debt Ratio
-503.2%

1953.4%

vs. 3-Year Avg.: 27.1%
ROE
265.9%

567.7%

vs. 3-Year Avg.: -56.8%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
신현진대표이사대표

Employment Status


Regular EmployeesContact
CEO신현진

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "대전광역시 유성구",
  "ceo_name": "신현진",
  "certificate": [
    {
      "cert_number": "20230427020003",
      "changes": "",
      "disclosure_date": "2023-04-27",
      "first_cert_date": "2023-04-27",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2023-04-27 ~ 2026-04-26"
    }
  ],
  "company_name": "(주)셀엔백스",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 388275000,
      "cost_of_sales": 0,
      "current_assets": 348284000,
      "current_liabilities": 28583000,
      "gross_profit": 0,
      "net_income": -189023000,
      "net_income_bs": -189248000,
      "non_current_assets": 263368000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 3330000,
      "non_operating_income": 977000,
      "operating_profit": -186670000,
      "revenue": 0,
      "sga_expenses": 186670000,
      "total_assets": 611652000,
      "total_equity": 583069000,
      "total_liabilities": 28583000
    },
    "2023": {
      "capital_stock": 388275000,
      "cost_of_sales": 0,
      "current_assets": 202788000,
      "current_liabilities": 8882000,
      "gross_profit": 0,
      "net_income": -261418000,
      "net_income_bs": -261418000,
      "non_current_assets": 277745000,
      "non_current_liabilities": 150000000,
      "non_operating_expenses": 1224000,
      "non_operating_income": 233000,
      "operating_profit": -260427000,
      "revenue": 0,
      "sga_expenses": 260427000,
      "total_assets": 480533000,
      "total_equity": 321651000,
      "total_liabilities": 158882000
    },
    "2024": {
      "capital_stock": 439275000,
      "cost_of_sales": 0,
      "current_assets": 650035000,
      "current_liabilities": 6007000,
      "gross_profit": 0,
      "net_income": -610803000,
      "net_income_bs": -610803000,
      "non_current_assets": 276234000,
      "non_current_liabilities": 1150000000,
      "non_operating_expenses": 13899000,
      "non_operating_income": 172813000,
      "operating_profit": -769717000,
      "revenue": 0,
      "sga_expenses": 769717000,
      "total_assets": 926269000,
      "total_equity": -229738000,
      "total_liabilities": 1156007000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "백신, 진단키트, 치료제 외",
  "phone": "042-821-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 6/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsNot Collected
Not Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
Employment Insurance2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected